Leading 10 Billion Series A with 5 Billion Investment
Betting on Past Investment Ties from Notus Era
Bio-specialized venture capital (VC) BNH Investment has invested in the pet healthcare startup ‘Onheal (ONHEAL).’ Leading the Series A investment, it has established itself as a reliable partner.
According to the investment banking (IB) industry on the 30th, BNH Investment participated in Onheal’s Series A investment round. This Series A round is worth 10 billion KRW. BNH Investment led the round by investing half, 5 billion KRW. The remaining 5 billion KRW will be executed by financial investors (FIs) such as venture capital and strategic investors (SIs).
Onheal pursues a business aimed at extending the lifespan of pets. Its main services include ▲home-based pet healthcare ‘PETHOMTH’ ▲veterinary research and development of animal pharmaceuticals and equipment through efficacy testing ▲offline chain shop ‘Onheal Pet’ selling products necessary for pet life ▲exclusive closed mall for animal hospitals ‘N.P.P (New Paradigm Platform).’
Kim Dohyung, CEO of Onheal, is the founder of HLB BioStep (formerly Notus), a KOSDAQ-listed non-clinical CRO company. After successfully listing Notus, he started a new venture and earned the title of serial entrepreneur.
BNH Investment also participated in Notus’s Series A round. They invested when the company was unlisted and successfully exited (recovered investment) after Notus went public. They have now become partners once again.
Onheal will also begin distributing ‘Kwangdong Gyeonyokgo One Premium,’ a dog health functional food exclusively for animal hospitals by Kwangdong Life & Health. Through a business agreement, both companies aim to promote mutual development and friendship in the pet market and plan to grow as a company contributing more to pet health through the sales of Kwangdong Gyeonyokgo One Premium.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
